SCINAI Ends PC111 Arrangements to Refocus on NanoAb and CDMO Work
Scinai says it has concluded its PC111 arrangements and will redirect capital to its NanoAb platform and expanding CDMO business.
Scinai says it has concluded its PC111 arrangements and will redirect capital to its NanoAb platform and expanding CDMO business.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.